Omics Experiments in Iran, a Review in Endocrine and Metabolism Disorders Studies

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2024 Nov 29

PMID 39610495

Authors

Shaghayegh Hosseinkhani

Babak Arjmand

Fatemeh Bandarian

Hossein Aazami

Nastaran Hadizadeh

Niloufar Najjar

Parvin Pasalar

Farideh Razi

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to evaluate the status of scientific research output of omics in regards to human diseases with more attention shifted toward endocrine and metabolism disorders in Iran, in order to find scientific gaps and also to design future plans for further investigations in this field.

Methods: Extensive search was performed in the electronic databases of Scopus and PubMed, and documents published by Iranian authors up to 27 December 2020 were extracted. Articles related to human diseases were included and categorized based on their types and topics.

Results: A total of 904 publications were found. Followed by checking their titles and abstracts, 327 studies were included. The trend of publication has been increasing during the past years. Regarding this subject, the highest number of publications was in the field of malignant disorders with 82 publications followed by reproductive system diseases and infectious diseases with 33 publications in each subject. Only 12 articles were found in the field of endocrinology and metabolism. The most popular techniques used in those reports were two-dimensional electrophoresis coupled with mass spectrometry (34.4 %) followed by NMR (22.6 %), LC/MS/MS (15 %).

Conclusions: Omics studies in Iran are a relatively new approach and the number of original articles regarding endocrine disorders in humans is limited. Providing appropriate infrastructures including lab facilities with high technology instruments can improve the quality and quantity of basic and clinical researches in this field.

References

Mehrparavar B, Minai-Tehrani A, Arjmand B, Gilany K . Metabolomics of Male Infertility: A New Tool for Diagnostic Tests. J Reprod Infertil. 2019; 20(2):64-69. PMC: 6486563. View

Rahimi N, Razi F, Nasli-Esfahani E, Qorbani M, Shirzad N, Larijani B . Amino acid profiling in the gestational diabetes mellitus. J Diabetes Metab Disord. 2017; 16:13. PMC: 5374565. DOI: 10.1186/s40200-016-0283-1. View

Hashemitabar M, Sabbagh S, Orazizadeh M, Ghadiri A, Bahmanzadeh M . A proteomic analysis on human sperm tail: comparison between normozoospermia and asthenozoospermia. J Assist Reprod Genet. 2015; 32(6):853-63. PMC: 4491089. DOI: 10.1007/s10815-015-0465-7. View

Vakilian H, Mirzaei M, Sharifi Tabar M, Pooyan P, Habibi Rezaee L, Parker L . DDX3Y, a Male-Specific Region of Y Chromosome Gene, May Modulate Neuronal Differentiation. J Proteome Res. 2015; 14(9):3474-83. DOI: 10.1021/acs.jproteome.5b00512. View

Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N . Metabolomics and Cell Therapy in Diabetes Mellitus. Int J Mol Cell Med. 2020; 8(Suppl1):41-48. PMC: 7175613. DOI: 10.22088/IJMCM.BUMS.8.2.41. View

Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M . Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine. 2019; 65(1):1-14. DOI: 10.1007/s12020-019-01904-1. View

Bagheri M, Djazayery A, Farzadfar F, Qi L, Yekaninejad M, Aslibekyan S . Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults. Lipids Health Dis. 2019; 18(1):94. PMC: 6456979. DOI: 10.1186/s12944-019-1037-0. View

Farrokhi Yekta R, Arefi Oskouie A, Rezaei Tavirani M, Mohajeri-Tehrani M, Soroush A . Decreased apolipoprotein A4 and increased complement component 3 as potential markers for papillary thyroid carcinoma: A proteomic study. Int J Biol Markers. 2018; 33(4):455-462. DOI: 10.1177/1724600818787752. View

Agharezaee N, Hashemi M, Shahani M, Gilany K . Male Infertility, Precision Medicine and Systems Proteomics. J Reprod Infertil. 2019; 19(4):185-192. PMC: 6328981. View

10.

Bagheri M, Farzadfar F, Qi L, Yekaninejad M, Chamari M, Zeleznik O . Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity. J Proteome Res. 2018; 17(4):1452-1462. DOI: 10.1021/acs.jproteome.7b00802. View

11.

Adamski J . Key elements of metabolomics in the study of biomarkers of diabetes. Diabetologia. 2016; 59(12):2497-2502. DOI: 10.1007/s00125-016-4044-y. View

12.

Gilany K, Mani-Varnosfaderani A, Minai-Tehrani A, Mirzajani F, Ghassempour A, Sadeghi M . Untargeted metabolomic profiling of seminal plasma in nonobstructive azoospermia men: A noninvasive detection of spermatogenesis. Biomed Chromatogr. 2017; 31(8). DOI: 10.1002/bmc.3931. View

13.

Bagheri M, Djazayery A, Qi L, Yekaninejad M, Chamari M, Naderi M . Effectiveness of vitamin D therapy in improving metabolomic biomarkers in obesity phenotypes: Two randomized clinical trials. Int J Obes (Lond). 2018; 42(10):1782-1796. DOI: 10.1038/s41366-018-0107-0. View

14.

Zhang A, Sun H, Wang P, Han Y, Wang X . Modern analytical techniques in metabolomics analysis. Analyst. 2011; 137(2):293-300. DOI: 10.1039/c1an15605e. View

15.

Gilany K, Jafarzadeh N, Mani-Varnosfaderani A, Minai-Tehrani A, Sadeghi M, Darbandi M . Metabolic Fingerprinting of Seminal Plasma from Non-obstructive Azoospermia Patients: Positive Versus Negative Sperm Retrieval. J Reprod Infertil. 2018; 19(2):109-114. PMC: 6010822. View

16.

Maleki A, Ramazani A, Foroutan M, Biglari A, Ranjzad P, Mellati A . Comparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats Kidneys Transfected with Adenovirus-mediated Fibromodulin Gene. Avicenna J Med Biotechnol. 2014; 6(2):104-12. PMC: 4009092. View

17.

Chashmniam S, Madani N, Nobakht Mothlagh Ghoochani B, Safari-Alighiarloo N, Khamseh M . The metabolome profiling of obese and non-obese individuals: Metabolically healthy obese and unhealthy non-obese paradox. Iran J Basic Med Sci. 2020; 23(2):186-194. PMC: 7211347. DOI: 10.22038/IJBMS.2019.37885.9004. View

18.

Arjmand B, Abdollahi M, Larijani B . Study Break: Precision Medicine: A New Revolution in Healthcare System. Iran Biomed J. 2017; 21(5):282-3. View

19.

Kazemi Khoo N, Iravani A, Arjmand M, Vahabi F, Lajevardi M, Akrami S . A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci. 2013; 28(6):1527-32. DOI: 10.1007/s10103-012-1247-4. View

20.

Khatami F, Payab M, Sarvari M, Gilany K, Larijani B, Arjmand B . Oncometabolites as biomarkers in thyroid cancer: a systematic review. Cancer Manag Res. 2019; 11:1829-1841. PMC: 6395057. DOI: 10.2147/CMAR.S188661. View